News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Read Simon
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/03/2020 |
4
| Read Simon (Chief Scientific Officer) has filed a Form 4 on Ra Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 12,595 shares
@ $48, valued at
$604.6k
Disposed/sold 46,434 options to buy
@ $2.87, valued at
$133.3k
Disposed/sold 26,422 options to buy
@ $2.87, valued at
$75.8k
Disposed/sold 25,000 options to buy
@ $5.6, valued at
$140k
Disposed/sold 67,500 options to buy
@ $16.64, valued at
$1.1M
Disposed/sold 55,000 options to buy
@ $7.33, valued at
$403.2k
Disposed/sold 107,000 options to buy
@ $21, valued at
$2.2M
Disposed/sold 9,166 restricted stock units
@ $0 |
|
| 12/18/2019 |
4
| Read Simon (Chief Scientific Officer) has filed a Form 4 on Ra Pharmaceuticals, Inc.|
Txns:
| Sold 10,000 shares
@ $47.0821, valued at
$470.8k
Exercised 10,000 options to buy
@ $2.87, valued at
$28.7k
|
|
| 11/18/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/17/2019 |
4
| Read Simon (Chief Scientific Officer) has filed a Form 4 on Ra Pharmaceuticals, Inc.|
Txns:
| Sold 10,000 shares
@ $46.8726, valued at
$468.7k
Exercised 10,000 options to buy
@ $2.87, valued at
$28.7k
|
|
| 09/16/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/27/2019 |
4
| Read Simon (Chief Scientific Officer) has filed a Form 4 on Ra Pharmaceuticals, Inc.|
Txns:
| Sold 10,000 shares
@ $27.7703, valued at
$277.7k
Exercised 10,000 options to buy
@ $2.87, valued at
$28.7k
|
|
| 07/18/2019 |
4
| Read Simon (Chief Scientific Officer) has filed a Form 4 on Ra Pharmaceuticals, Inc.|
Txns:
| Sold 10,000 shares
@ $32.9479, valued at
$329.5k
Exercised 10,000 options to buy
@ $2.87, valued at
$28.7k
|
|
| 06/19/2019 |
4
| Read Simon (Chief Scientific Officer) has filed a Form 4 on Ra Pharmaceuticals, Inc.|
Txns:
| Sold 9,586 shares
@ $22.2103, valued at
$212.9k
Sold 414 shares
@ $23.0906, valued at
$9.6k
Exercised 10,000 options to buy
@ $2.87, valued at
$28.7k
|
|
| 02/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2018 |
4
| Read Simon (Chief Scientific Officer) has filed a Form 4 on Ra Pharmaceuticals, Inc.|
Txns:
| Granted 55,000 options to buy
@ $7.33, valued at
$403.2k
Granted 27,500 restricted stock units
@ $0 |
|
| 02/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/25/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|